Provided by Tiger Trade Technology Pte. Ltd.

Nasdaq

93.65
+1.281.39%
Post-market: 93.07-0.5798-0.62%19:49 EDT
Volume:1.83M
Turnover:171.25M
Market Cap:52.35B
PE:27.31
High:93.95
Open:92.50
Low:92.50
Close:92.37
52wk High:101.79
52wk Low:76.55
Shares:559.00M
Float Shares:496.00M
Volume Ratio:0.56
T/O Rate:0.37%
Dividend:1.12
Dividend Rate:1.20%
EPS(TTM):3.43
EPS(LYR):3.09
ROE:16.52%
ROA:5.85%
PB:4.37
PE(LYR):30.31

Loading ...

Piedmont Realty Trust to Report Third-Quarter Financial Results After Market Close

Reuters
·
Oct 06

Proficient Auto Logistics Publishes Update to Financial Calendar

Reuters
·
Oct 06

Vaxcyte Launches USD 500 Million Convertible Senior Notes Offering Due 2032

Reuters
·
Oct 06

authID Prices USD 1.35 Million Senior Secured Convertible Debenture Offering

Reuters
·
Oct 06

Kite Realty Group Schedules Q3 Financial Results Release, Earnings Call

Reuters
·
Oct 06

Uniti Group to Report Q3 2026 Results, Host Earnings Call

Reuters
·
Oct 06

Merlin to Attend Maxim Growth Summit 2026

Reuters
·
Oct 06

Korro Bio Doses First Healthy-Volunteer Cohort in Phase 1/2 Anchor Trial of KRRO-121

Reuters
·
Oct 06

Inspire Medical Systems to Report Q3 2026 Results, Host Conference Call

Reuters
·
Oct 06

Eledon to Present Phase 2 Bestow Kidney Transplant Trial Patient-Reported Outcomes for Tegoprubart at ASN Kidney Week 2026

Reuters
·
Oct 06

Alamar Biosciences Names Former GRAIL CEO Bob Ragusa to Board

Reuters
·
Oct 06

Aligos Therapeutics to Present New Pevifoscorvir Sodium Clinical Data in Chronic Hepatitis B at AASLD Liver Meeting 2026

Reuters
·
Oct 06

CTW Updates Financial Calendar for Fiscal 2026 Results Release, Earnings Webinar

Reuters
·
Oct 06

Sprout Social Schedules Third-Quarter Results Release and Conference Call

Reuters
·
Oct 06

Equillium Wins Australian Regulatory Clearance for EQ504 Phase 1 Trial

Reuters
·
Oct 06

Universal Health Services Updates Financial Calendar with Third-Quarter Earnings Release, Conference Call Schedule

Reuters
·
Oct 06

Neostellar Capital Publishes Q3 2026 Preliminary Update, Estimates Sept. 30 NAV at USD 12.25-$12.75/share

Reuters
·
Oct 06

NanoXplore Unit VoltaXplore Names Galvion Founder Jonathan Blanshay to Advisory Board

Reuters
·
Oct 06

Mulvihill Premium Global Income Split Fund Declares October Monthly Distributions of $0.08 a Share on Class a Shares

Reuters
·
Oct 06

Spyre Therapeutics Launches Underwritten Public Offering of Common Stock

Reuters
·
Oct 06